Do you offer melanoma epitope peptide antigen recognized by T cells?
Bio-Synthesis offers various collection of melanoma immunodominannt epitopes that recognized by T-cell for cancer research. Melanoma, a malignant tumor that derived in melanocytes, is the leading cause of skin cancer deaths. Several peptide antigen expressed in melanoma cells are recognized by T cells are been identified and been used in developing immunization approaches for tumor regression. Example of few melanoma peptide epitopes are:
- [Ala26]-Melan-A/MART-1 (26-35)
- Melan-A/MART-1 (27-35)
- Melan-A, MART 1 (26-35)
- [Leu27]-Melan-A,
- MART 1 (26-35)
- Melan-A/MART-1 (24-34)
- Melan-A/MART-1 (32-40)
- Melanocyte Associated Antigen gp 100 (17-25)
- Melanocyte Associated Antigen gp100
- gp100 (476-485)
- gp100 (570–579)
- gp100 (457-466) gp100 (614–622)
- gp100 (639–647) gp100 (619–627)
- gp100 (178-187)
- [Asp370]-Tyrosinase (368-376)
- (Asn370) tyrosinase (368–376)
- Tyrosinase (1-9)
- Tyrosinase (146-156)
- Tyrosinase (206-214), T9206
- Tyrosinase (192-200)
- Tyrosinase (56-70)
- Tyrosinase (450-462)
- Tyrosinase (243-251), core nonamer sequence
- Tyrosinase (240-251)
Contact us for Melanoma Peptide Epitope Synthesis.
Print
05/29/2014